Westside Investment Management, Inc. Eton Pharmaceuticals, Inc. Transaction History

Westside Investment Management, Inc.

$469 Billion
Q1 2025

A detailed history of Westside Investment Management, Inc. transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Westside Investment Management, Inc. holds 493,650 shares of ETON stock, worth $7.71 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares

493,650

Previous 575,222 14.18%

Holding current value

$7.71 Million

Previous $7.66 Billion 16.37%

% of portfolio

1.36%

Previous 1.61%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	SELL	$11.75 - $18.25 $958,471 - $1.49 Million	-81,572 Reduced 14.18%	493,650 $6.41 Billion
Q4 2024 Jan 17, 2025	SELL	$5.9 - $13.15 $256,372 - $571,406	-43,453 Reduced 7.02%	575,222 $7.66 Billion
Q3 2024 Nov 20, 2024	BUY	$3.28 - $6.0 $109,142 - $199,650	33,275 Added 5.68%	618,675 $3.71 Billion
Q2 2024 Jul 17, 2024	BUY	$3.06 - $3.75 $35,006 - $42,900	11,440 Added 1.99%	585,400 $1.93 Billion
Q1 2024 Apr 19, 2024	BUY	$3.48 - $5.03 $37,758 - $54,575	10,850 Added 1.93%	573,960 $2.15 Billion
Q4 2023 Jan 12, 2024	BUY	$3.45 - $4.66 $120,060 - $162,168	34,800 Added 6.59%	563,110 $2.47 Billion
Q3 2023 Nov 15, 2023	BUY	$2.55 - $5.63 $23,100 - $51,002	9,059 Added 1.74%	528,310 $2.2 Billion
Q2 2023 Jul 14, 2023	BUY	$3.32 - $4.04 $6,474 - $7,878	1,950 Added 0.38%	519,251 $1.81 Billion
Q1 2023 May 17, 2023	SELL	$2.89 - $4.1 $106,641 - $151,290	-36,900 Reduced 6.66%	517,301 $1.99 Billion
Q4 2022 Jan 31, 2023	BUY	$2.02 - $3.25 $165,337 - $266,012	81,850 Added 17.33%	554,201 $3.01 Million
Q3 2022 Nov 09, 2022	BUY	$2.04 - $3.03 $258,674 - $384,207	126,801 Added 36.7%	472,351 $2.04 Million
Q2 2022 Jul 15, 2022	BUY	$2.55 - $4.38 $263,491 - $452,585	103,330 Added 42.66%	345,550 $905,000
Q1 2022 Apr 25, 2022	BUY	$3.43 - $4.69 $424,273 - $580,129	123,695 Added 104.36%	242,220 $1.06 Million
Q4 2021 Feb 15, 2022	BUY	$3.66 - $6.59 $48,403 - $87,152	13,225 Added 12.56%	118,525 $508,000
Q3 2021 Oct 27, 2021	BUY	$4.2 - $6.26 $14,700 - $21,910	3,500 Added 3.44%	105,300 $530,000
Q2 2021 Jul 28, 2021	BUY	$5.71 - $8.85 $87,220 - $135,183	15,275 Added 17.65%	101,800 $627,000
Q1 2021 Apr 14, 2021	BUY	$6.93 - $10.07 $18,191 - $26,433	2,625 Added 3.13%	86,525 $633,000
Q4 2020 Jan 15, 2021	BUY	$6.65 - $8.83 $5,652 - $7,505	850 Added 1.02%	83,900 $682,000
Q3 2020 Oct 14, 2020	BUY	$4.96 - $9.06 $4,960 - $9,060	1,000 Added 1.22%	83,050 $656,000
Q2 2020 Jul 21, 2020	BUY	$3.5 - $6.09 $120,050 - $208,887	34,300 Added 71.83%	82,050 $447,000
Q1 2020 Apr 16, 2020	BUY	$2.87 - $7.47 $137,042 - $356,692	47,750 New	47,750 $195,000

Others Institutions Holding ETON

# of Institutions

Shares Held

14M

Call Options Held

61.2K

Put Options Held

33.1K

View Full List

About Eton Pharmaceuticals, Inc.

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $395M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

More about ETON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.

Account

Westside Investment Management, Inc. Eton Pharmaceuticals, Inc. Transaction History